Literature DB >> 33562306

Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment.

Concetta Altamura1, Maria Raffaella Greco1,2, Maria Rosaria Carratù1, Rosa Angela Cardone2, Jean-François Desaphy1.   

Abstract

Ovarian cancer (OC) is the deadliest gynecologic cancer, due to late diagnosis, development of platinum resistance, and inadequate alternative therapy. It has been demonstrated that membrane ion channels play important roles in cancer processes, including cell proliferation, apoptosis, motility, and invasion. Here, we review the contribution of ion channels in the development and progression of OC, evaluating their potential in clinical management. Increased expression of voltage-gated and epithelial sodium channels has been detected in OC cells and tissues and shown to be involved in cancer proliferation and invasion. Potassium and calcium channels have been found to play a critical role in the control of cell cycle and in the resistance to apoptosis, promoting tumor growth and recurrence. Overexpression of chloride and transient receptor potential channels was found both in vitro and in vivo, supporting their contribution to OC. Furthermore, ion channels have been shown to influence the sensitivity of OC cells to neoplastic drugs, suggesting a critical role in chemotherapy resistance. The study of ion channels expression and function in OC can improve our understanding of pathophysiology and pave the way for identifying ion channels as potential targets for tumor diagnosis and treatment.

Entities:  

Keywords:  chemoresistance; drug resistance; ion channels; ovarian cancer

Year:  2021        PMID: 33562306      PMCID: PMC7914442          DOI: 10.3390/cancers13040668

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  204 in total

Review 1.  Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.

Authors:  Roi Tschernichovsky; Annekathryn Goodman
Journal:  Oncologist       Date:  2017-03-17

2.  High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo.

Authors:  Jiao Xu; Min Yong; Jia Li; Xiaojing Dong; Tinghe Yu; Xiao Fu; Lina Hu
Journal:  Oncol Rep       Date:  2015-03-03       Impact factor: 3.906

3.  Mammalian PIK3C3/VPS34: the key to autophagic processing in liver and heart.

Authors:  Nadia Jaber; Zhixun Dou; Richard Z Lin; Jianhua Zhang; Wei-Xing Zong
Journal:  Autophagy       Date:  2012-04-01       Impact factor: 16.016

4.  Orai1 and STIM1 are critical for breast tumor cell migration and metastasis.

Authors:  Shengyu Yang; J Jillian Zhang; Xin-Yun Huang
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

5.  TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis.

Authors:  Bo Zeng; Cunzhong Yuan; Xingsheng Yang; Stephen L Atkin; Shang-Zhong Xu
Journal:  Curr Cancer Drug Targets       Date:  2013-01       Impact factor: 3.428

6.  Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.

Authors:  Xiaokui Yang; Fang Zheng; Hui Xing; Qinglei Gao; Wang Wei; Yunping Lu; Shixuan Wang; Jianfeng Zhou; Wei Hu; Ding Ma
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

7.  T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.

Authors:  Barbara Dziegielewska; Eli V Casarez; Wesley Z Yang; Lloyd S Gray; Jaroslaw Dziegielewski; Jill K Slack-Davis
Journal:  Mol Cancer Ther       Date:  2016-02-01       Impact factor: 6.261

8.  It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug.

Authors:  Ana C Mesa-Arango; Liliana Scorzoni; Oscar Zaragoza
Journal:  Front Microbiol       Date:  2012-08-08       Impact factor: 5.640

9.  hERG1 is involved in the pathophysiological process and inhibited by berberine in SKOV3 cells.

Authors:  Duo Zhi; Kun Zhou; Dahai Yu; Xiaofan Fan; Juan Zhang; Xiang Li; Mei Dong
Journal:  Oncol Lett       Date:  2019-04-17       Impact factor: 2.967

10.  CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer.

Authors:  Bipradeb Singha; Sandra L Harper; Aaron R Goldman; Benjamin G Bitler; Katherine M Aird; Mark E Borowsky; Mark G Cadungog; Qin Liu; Rugang Zhang; Stephanie Jean; Ronny Drapkin; David W Speicher
Journal:  Sci Rep       Date:  2018-10-03       Impact factor: 4.379

View more
  3 in total

Review 1.  Therapeutic potential of marine peptides in cervical and ovarian cancers.

Authors:  Salman Ahmed; Haroon Khan; Sajad Fakhri; Michael Aschner; Wai San Cheang
Journal:  Mol Cell Biochem       Date:  2021-12-02       Impact factor: 3.396

Review 2.  Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives.

Authors:  Ilaria Saltarella; Concetta Altamura; Aurelia Lamanuzzi; Benedetta Apollonio; Angelo Vacca; Maria Antonia Frassanito; Jean-François Desaphy
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 3.  Ion Channel Involvement in Tumor Drug Resistance.

Authors:  Concetta Altamura; Paola Gavazzo; Michael Pusch; Jean-François Desaphy
Journal:  J Pers Med       Date:  2022-02-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.